Vicarious Surgical Inc. (RBOT)

OQB – Real Time Price. Currency in USD

0.55

-0.05 (-8.33%)

At close: May 12, 2026, 9:52 AM EDT

30.04.2026

Vicarious Surgical Reports First Quarter 2026 Financial Results

WALTHAM, Mass., April 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCQB: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the first quarter ended March 31, 2026.

30.03.2026

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

WALTHAM, Mass., March 30, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced the successful completion of initial integrated benchtop testing for its full suite of surgical instruments, required for its anticipated first clinical indication of ventral hernia repair, marking an important step toward design validation, clinical readiness, and the Company's targeted design freeze milestone.

25.03.2026

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

WALTHAM, Mass., March 25, 2026 (GLOBE NEWSWIRE) -- Vicarious Surgical Inc. (OTCQB: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery (the “Company”), today announced that it has received approval for its Class A common stock to upgrade to the OTCQB® Venture Market by OTC Markets Group Inc. (the “OTCQB”).

16.03.2026

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (OTCID: RBOT), a next-generation robotics technology company seeking to transform minimally invasive surgery, today announced a series of strategic actions intended to strengthen the Company's financial position, enhance trading liquidity, and support a potential relisting of its common stock on a national exchange. Over the past several months, Vicarious Surgical has implemented significant operational and cost discipline initiatives des.

09.03.2026

Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (OTCID: RBOT), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Results Total operating expenses were $9.3 million in the fourth quarter of 2025, and $15.0 million in the fourth quarter of 2024, a decrease of 38%. Researc.

04.03.2026

Vicarious Surgical Receives Delisting Notice From NYSE

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical Inc. (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced that on March 3, 2026, it received a notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that the NYSE has commenced the process of delisting the Company's Class A common stock, par value $0.0001 per share (the “Common Stock”). Trading on the Company's Common Stock on the NYS.

03.03.2026

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange (“NYSE”, the “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the Class A common stock of Vicarious Surgical Inc. (the “Company”) — ticker symbol RBOT — from the NYSE. Trading in the Company's Class A common stock will be suspended immediately. NYSE Regulation reached its decision to delist the Company's Class A common stock pursuant to Section 802.01B of the NYSE's Listed Compan.

Videos

No Data

There is no data to display

Press releases

30.04.2026

Vicarious Surgical Reports First Quarter 2026 Financial Results

30.03.2026

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

25.03.2026

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

16.03.2026

Vicarious Surgical Inc. (RBOT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vicarious Surgical Inc. (RBOT)

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results

Vicarious Surgical Receives Delisting Notice From NYSE

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

Videos

No Data

Press releases

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results

Vicarious Surgical Receives Delisting Notice From NYSE

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

Videos

No Data

Press releases

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Search stocks

Vicarious Surgical Inc. (RBOT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Vicarious Surgical Inc. (RBOT)

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results

Vicarious Surgical Receives Delisting Notice From NYSE

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

Videos

No Data

Press releases

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing

Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results

Vicarious Surgical Receives Delisting Notice From NYSE

NYSE to Commence Delisting Proceedings Against Vicarious Surgical Inc. (RBOT)

Videos

No Data

Press releases

Vicarious Surgical Reports First Quarter 2026 Financial Results

Vicarious Surgical Completes Integrated Benchtop Testing of Full Surgical Instrument Suite for Ventral Hernia Repair

Vicarious Surgical Begins Quotation on the OTCQB as Part of Strategic Path Toward Potential Nasdaq Listing

Vicarious Surgical Announces Strategic Plan to Pursue Nasdaq Listing